Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Efficascent Oil - Extra Strength - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Efficascent Oil - Extra Strength

Approved

STANDARD

Efficascent Oil - Extra Strength

International Pharmaceuticals Inc.🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: ff6e0365d00a1625
Company: International Pharmaceuticals Inc.
Type: Standard

Approval Details

Approval Id: ff6e0365d00a1625
Drug Approval Philippines Name: Efficascent Oil - Extra Strength
Product Name: Efficascent Oil - Extra Strength
Registration Number: DRHR-2120
Brand Name: Efficascent Oil - Extra Strength
Generic Name: Methyl Salicylate + Camphor + Menthol
Dosage Form: Liniment
Dosage Strength: 225 mg / 75 mg / 60 mg per mL
Manufacturer: International Pharmaceuticals Inc.
Issuance Date: 28 January 2022
Expiry Date: 28 January 2029
Pharmacologic Category: Counterirritant
Classification: Household Remedy (HR)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

ff6e0365d00a1625

Type

Standard

Back to Philippines FDA Approvals